BioAge Labs Inc. (BIOA) vs Keros Therapeutics, Inc. (KROS)
A side-by-side comparison of BioAge Labs Inc. and Keros Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.31HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
KROS
Keros Therapeutics, Inc.
$11.41HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
Total return — BIOA vs KROS
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)KROS -79.7% (-55.0%/yr)BIOA compounded faster over this window
BIOA KROS
BIOA vs KROS: by the numbers
- •BIOA is the larger company ($237M vs $226M market cap).
- •Both run net losses; KROS's is the smaller (-553.88% vs -912.25% net margin).
Metrics side by side
Valuation
| Metric | BIOA | KROS |
|---|---|---|
| P/S ratio | 22.92 | 15.06 |
| P/B ratio | 0.63 | 0.86 |
Profitability
| Metric | BIOA | KROS |
|---|---|---|
| Gross margin | 99.39% | 94.68% |
| Operating margin | -1026.28% | 28.94% |
| Net margin | -912.25% | -553.88% |
| ROE | -25.20% | -31.70% |
| ROIC | -28.14% | -36.49% |
Growth (annualized)
| Metric | BIOA | KROS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 172.50% |
| Total return CAGR (5Y) | N/A | -21.98% |
Go deeper
Dig into the metrics
BioAge Labs ROEKeros Therapeutics ROEBioAge Labs operating marginKeros Therapeutics operating marginBioAge Labs revenue growthKeros Therapeutics revenue growthBioAge Labs free cash flowKeros Therapeutics free cash flow
BioAge Labs & Keros Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.